Many of the fusions analyzed in this work (7/12) are fusions with MLLT10 which, although relatively frequent in leukemia (~13% of KMT2A fusions in adult AML as reported by Meyer et al. [16]), tend to be cryptic. The gene discussed is MLLT10; the disease is leukemia.